Ildong to introduce novel weight loss drug

Published: 2012-11-09 06:59:00

Updated: 2012-11-09 06:59:00

Ildong Pharm said Wednesday that it has entered into a marketing and supply agreement with Arena Pharmaceuticals GmbH for BELVIQ (lorcaserin HCl). BELVIQ is believed to decrease food consumption and promote satiety by selectively activating serotonin 2C receptors in the brain. Activation of these...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK